A Phase I Clinical Trial Of Hepatic Arterial Infusion Of Oxaliplatin And Oral Capecitabine, With Or Without Systemic Bevacizumab, For Patients With Advanced Cancer And Liver Involvement.
JOURNAL OF CLINICAL ONCOLOGY(2018)
摘要
2527Background: Hepatic arterial infusion (HAI) of chemotherapy is a treatment option for patients (pts) with cancer metastatic to the liver. We investigated HAI oxaliplatin combined with capecitab...
更多查看译文
关键词
hepatic arterial infusion,systemic bevacizumab,oxaliplatin,oral capecitabine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络